Description
The flexible tail of the hemostatic enzyme adamts13 is able to shield the active site
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: The flexible tail of the hemostatic enzyme adamts13 is able to shield the active site
€2.42
